Clinical Trial Update: Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating weekly exenatide injections as an adjunctive treatment for schizophrenia and schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2021-06-15